Efficacy News and Research

RSS

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

One of the strategies adopted consists in utilizing combinations of fixed doses of generic antiretrovirals, involving three medicinal drugs of two different classes in the same tablet.

2 Jul 2004

Physical activity cuts risk of depression in children

Students who increase their physical activity during their middle-school years have fewer symptoms of depression, according to a new study.

1 Jul 2004

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.

1 Jul 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

A Center for Human Genetics/Genomics has been established at the University of California

Established in UCSD Health Sciences, which includes the School of Medicine and School of Pharmacy and Pharmaceutical Sciences, the Center brings together UCSD faculty from multiple campus departments and schools including medicine, pharmacy, biology, biostatistics and mathematics.

30 Jun 2004

Request for further evidence about the risks and benefits of the painkiller co-proxamol

The MHRA today issued a request for any further evidence about the risks and benefits of the painkiller co-proxamol, as part of an ongoing review being carried out by Committee on the Safety of Medicines (CSM).

30 Jun 2004

Alcon updates filing status of RETAANE® new drug application

Alcon, Inc. has announced that it has filed the second portion of its “rolling” New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for RETAANE® 15mg (anecortave acetate for depot suspension)

30 Jun 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

Exelixis files new drug application for a proprietary novel anticancer compound

Exelixis, Inc. has submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration (FDA) for XL999, a proprietary novel anticancer compound.

29 Jun 2004

Prince Charles has called for more research into the benefits of complementary therapies for cancer patients

His Royal Highness was speaking at a conference hosted by five major charities, including The Prince of Wales’s Foundation for Integrated Health of which he is President.

28 Jun 2004

World is currently facing a twin epidemic of obesity and type 2 diabetes in young people

The global rise in obesity and type 2 diabetes in children and adolescents has led to an urgent call for action by the International Diabetes Federation (IDF).

25 Jun 2004

Atkins responds to recent attacks from industry-funded groups

Atkins Health & Medical Information Services is urging Americans to once again look to the Atkins Lifestyle Food Guide Pyramid

25 Jun 2004

Most Alzheimer's drugs don't work

A new UK study published in THE LANCET concludes that the most widely used drugs to treat Alzheimer's disease have only minimal efficacy, and that an alternative approach for treatment is needed.

24 Jun 2004

Residency training is demanding, leading busy residents to forfeit sleep

Federal mandates last year capped the resident’s work week at 80 hours, reducing the amount of time spent in the operating room and in the hospital treating patients.

23 Jun 2004

New guidelines to develop reliable information for consumer use of alternative medicines

Since traditional, complementary and alternative medicines remain largely unregulated, consumers worldwide need to be informed and given the tools to access appropriate, safe and effective treatment.

23 Jun 2004

WHO removes two antiretroviral products from the WHO List of prequalified products

The World Health Organization (WHO) removed two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Drug for multiple sclerosis prevented disease development when tested on animal models

Scientists from the Neurological Sciences Institute at Oregon Health & Science University have shown that an investigative drug for multiple sclerosis and related diseases prevented disease development when tested on animal models.

20 Jun 2004

Valsartan may reduce cardiac illness and death

Results of a study in this week's issue of THE LANCET provide further evidence that a class of drugs that lower blood pressure are a treatment option for older people at high cardiovascular risk. The study also emphasises the importance of early blood-pressure lowering after the start of treatment to reduce the risk of cardiovascular events such as heart attack and stroke.

17 Jun 2004

Intrinsa patch increases sexual desire in menopausal women

Data released from a second, large-scale safety and efficacy study showed treatment with Intrinsa, an investigational female testosterone patch, significantly increased satisfying sexual activity and sexual desire in menopausal women

17 Jun 2004

Australian researchers have identified the hormone DHEAS as a new marker of low libido in women under 45 years

Researchers at the Australian based Jean Hailes Foundation are addressing the complex role of hormones. Their aim is to understand what is normal and whether women may benefit from therapy. In one of the world’s most comprehensive studies into women’s health and hormones researchers looked at 1423 randomly selected women aged 18-75.

17 Jun 2004

Efficacy News and Research

Access to HIV antiretroviral therapies in the developing world should be a major world health priority

Physical activity cuts risk of depression in children

New drug application for cilansetron, an investigational product for the treatment of irritable bowel syndrome

TUNA therapy results in significantly reduced erectile dysfunction

A Center for Human Genetics/Genomics has been established at the University of California

Request for further evidence about the risks and benefits of the painkiller co-proxamol

Alcon updates filing status of RETAANE® new drug application

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Exelixis files new drug application for a proprietary novel anticancer compound

Prince Charles has called for more research into the benefits of complementary therapies for cancer patients

World is currently facing a twin epidemic of obesity and type 2 diabetes in young people

Atkins responds to recent attacks from industry-funded groups

Most Alzheimer's drugs don't work

Residency training is demanding, leading busy residents to forfeit sleep

New guidelines to develop reliable information for consumer use of alternative medicines

WHO removes two antiretroviral products from the WHO List of prequalified products

Drug for multiple sclerosis prevented disease development when tested on animal models

Valsartan may reduce cardiac illness and death

Intrinsa patch increases sexual desire in menopausal women

Australian researchers have identified the hormone DHEAS as a new marker of low libido in women under 45 years

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News